Corbenic Partners’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
$1K Sell
20
-40
-67% -$2K ﹤0.01% 196
2022
Q1
$4K Sell
60
-660
-92% -$44K ﹤0.01% 185
2021
Q4
$55K Sell
720
-45
-6% -$3.44K 0.01% 81
2021
Q3
$86K Hold
765
0.02% 73
2021
Q2
$124K Hold
765
0.03% 60
2021
Q1
$93K Buy
+765
New +$93K 0.02% 69